Name
Session II: Advanced Cell and Immune- Based Therapies
Date & Time
Monday, September 28, 2026, 9:20 AM - 10:20 AM
Speakers
Wei-Li Zhao, MD, PhD, Shanghai Institute of Hematology, Shanghai Ruijin Hospital
Bas Baaten, PhD, Pfizer
Bas Baaten, PhD, Pfizer
Description
9:20 AM Shaping the Next Generation of T Cell Engagers: Strategies for Efficacy, Selectivity, and Safety
Bas Baaten, PhD, Pfizer
9:50 AM How Lymphoma Contributes to Advanced Cell and Immune-Based Therapies
Wei-Li Zhao, MD, PhD, Shanghai Institute of Hematology, Shanghai Ruijin Hospital